Zura Bio Limited (ZURA) financial statements and ratios from SEC XBRL: revenue $6.34M (TTM), net margin -1083.5%, revenue growth 11.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $6.34M |
| Net Margin | -1083.5% |
| Revenue Growth (YoY) | 11.8% |
| EPS Growth (YoY) | 23.5% |
| FCF Growth (YoY) | -217.8% |
| Price / Book | 2.81 |
| Price / Sales | 91.84 |
| FCF Yield | -6.8% |
| Altman Z-Score | 22.96 (safe) |
| Sector P/E (Healthcare) | 21.7 |
ZURA overview · ZURA earnings · ZURA KPIs · ZURA investor relations · ZURA ownership · ZURA peers · ZURA filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.